Evidence map›Paper›PMID 25332785›Full record

ArticleOpen heart

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update.

O De Backer, S Arnous, N Ihlemann, N Vejlstrup, E Jørgensen, S Pehrson, T D W Krieger, P Meier, L Søndergaard, O W Franzen

Abstract read
In one paragraph

Article in Open heart. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Transcatheter Left Atrial Appendage Closure.Methodist DeBakey cardiovascular journal · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Comparison of echocardiographic and fluoroscopic sizing of the left atrial appendage prior to percutaneous closure.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Current State of Left Atrial Appendage Closure.Current cardiology reports · 2018
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Heart within a Heart.Journal of cardiovascular ultrasound · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

O De BackerDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
S ArnousDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
N IhlemannDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
N VejlstrupDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
E JørgensenDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
S PehrsonDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
T D W KriegerDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
P MeierDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
L SøndergaardDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.
O W FranzenDepartment of Cardiology , Rigshospitalet , Copenhagen Ø , Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. One of its most devastating complications is the development of thromboembolism leading to fatal or disabling stroke. Oral anticoagulation (OAC, warfarin) is the standard treatment for stroke prevention in patients with AF with an increased stroke risk. However, there are several obstacles to long-term OAC therapy, including the risk of serious bleeding, several drug-drug interactions and the need for frequent blood testing. Although newer oral anticoagulants have been developed, these drugs also face issues of major bleeding and non-compliance. Therefore, alternative treatment options for stroke prevention in patients with AF with a high stroke risk are needed. Percutaneous left atrial appendage (LAA) occlusion is an evolving therapy, which should be taken into consideration in those patients with non-valvular AF with a high stroke risk and contraindications for OAC. This article aims to discuss the rationale for LAA closure, the available LAA occlusion devices and their clinical evidence until now. Moreover, we discuss the importance of proper patient selection, the role of various imaging techniques and the need for a more tailored postprocedural antithrombotic therapy.

Indexed as

Allied Specialities

Identifiers

PMID25332785
PMCPMC4195925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.